Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human CD30/TNFRSF8 Antibody, R&D Systems™

Mouse Monoclonal Antibody has been used in 3 publications
Supplier: R&D Systems MAB229
This item is not returnable.
View return policy
Description
CD30/TNFRSF8 Monoclonal specifically detects CD30/TNFRSF8 in Human samples. It is validated for Western Blot, Flow Cytometry, Agonist Activity, CyTOF-ready.Specifications
CD30/TNFRSF8 | |
Monoclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, TNFRSF8, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8 | |
Mouse | |
Protein A or G purified from ascites | |
RUO | |
Primary | |
Detects human CD30/TNFRSF8 in direct ELISAs and Western blots. In direct ELISAs, less than 1% cross-reactivity with recombinant mouse CD30, recombinant human (rh) CD27, and rhCD40 is observed. | |
Human | |
Purified |
Western Blot, Flow Cytometry, CyTOF | |
81337 | |
Western Blot 1 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, Agonist Activity 0.05-0.2 ug/mL, CyTOF-ready | |
P28908 | |
TNFRSF8 | |
S. frugiperda insect ovarian cell line Sf 21-derived recombinant human CD30/TNFRSF8 Phe19-Lys379 Accession # P28908 | |
500 μg | |
Agonist Activity | |
943 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2b |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction